• Text size      
  • Send this article to a friend
  • Print this article

Drug hopes after malaria find

Scientists have discovered an "exciting" compound that could be developed into a new antimalarial drug.

The find was made by a team at Dundee University's Drug Discovery Unit, which has been working with non-profit foundation Medicines for Malaria Venture (MMV) to find new treatments.

It is hoped the compound could begin human clinical trials in the next 18 months after it was recommended for development by MMV's expert scientific advisory committee.

There are estimated to be more than 200 million cases of malaria worldwide each year, resulting in about 627,000 deaths, mostly among children under five.

Scientists say there is an urgent need for new, effective and affordable drugs as the parasite that causes malaria is developing resistance to current medicines.

Professor Ian Gilbert, chairman of medicinal chemistry at the university and one of the project leaders, said: "This compound has impressive antimalarial properties. It has potential for a single dose treatment of malaria."

Co-project leader Dr Kevin Read said: "We are very excited by this compound which belongs to a different chemical class to current antimalarial drugs."

Contextual targeting label: 
Drugs

Commenting & Moderation

We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis.
If you're a relatively new user then your comments will be reviewed before publication and if we know you well and trust you then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.

210691